Assessment of Resistance Mechanisms and Clinical Implications in Patients With<i>EGFR</i>T790M–Positive Lung Cancer and Acquired Resistance to OsimertinibGeoffrey R. Oxnard, Pasi A. Jänne, Nora Feeney et al.|JAMA Oncology|2018Cited by 689
Prospective Validation of Rapid Plasma Genotyping for the Detection of<i>EGFR</i>and<i>KRAS</i>Mutations in Advanced Lung CancerAdrian G. Sacher, Geoffrey R. Oxnard, Cloud P. Paweletz et al.|JAMA Oncology|2016Cited by 567
False-Positive Plasma Genotyping Due to Clonal HematopoiesisYuebi Hu, Geoffrey R. Oxnard, Cloud P. Paweletz et al.|Clinical Cancer Research|2018Cited by 445